{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[["9MW2821","toripalimab"]],"indication":null,"name":"NCT06079112","nct_id":"NCT06079112","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct06079112. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":null,"label":"9MW2821+Toripalimab","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2027-12-31","type":"ESTIMATED"},"conditions":["Advanced Urothelial Carcinoma"],"enrollment":{"count":100,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"9MW2821","otherNames":["9MW2821 injection"],"type":"DRUG"},{"name":"Toripalimab","otherNames":["Toripalimab injection"],"type":"DRUG"}],"last_update":"2024-09-19","lead_sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","official_title":"A Phase Ib/II, Open-label, Single Arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer","overall_status":"RECRUITING","phases":["PHASE1","PHASE2"],"primary_completion_date":{"date":"2026-12-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"incidence of AE/SAE","timeFrame":"Up to 24 months"}],"references":[],"start_date":{"date":"2023-09-27","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer","url":"https://clinicaltrials.gov/study/NCT06079112"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct06079112"}